(Q57837650)

English

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma

article by Christoph Seidel et al published May 2012 in European Journal of Cancer

Statements

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma (English)
0 references
0 references
Christoph Seidel
0 references
Jonas Busch
0 references
Steffen Weikert
0 references
Sandra Steffens
0 references
Arnold Ganser
0 references
Viktor Grünwald
0 references
May 2012
0 references
48
0 references
7
0 references
1023-1030
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit